Skip to search formSkip to main contentSkip to account menu

Zerit

Known as: Bristol-Myers Brand of Stavudine, Bristol-Myers Squibb Brand of Stavudine 
National Institutes of Health

Related topics

Related topics

3 relations
BMY-27857Stavudine 40 MG Oral Capsule [Zerit]

Broader (1)

Stavudine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Acute psychosis under efavirenz in a HIV patient.
BACKGROUND Efavirenz is one of the most prescribed HIV drugs, it can have number of psychiatric adverse effects varying from… 
2003
2003
The Preparedness of national secondary school teachers in Nairobi Province to implement HIV/AIDS Education curriculum
xv 
2002
2002
HIV drug stavudine (Zerit, d4T) and symptoms mimicking Guillain-Barré syndrome.
  • E. Wooltorton
  • CMAJ : Canadian Medical Association journal…
  • 2002
  • Corpus ID: 43292647
Reason for posting: In a warning letter to physicians Bristol-Myers Squibb has reported 22 cases (including 7 deaths) worldwide… 
2002
2002
The Law of the Lab: Using Zerit to Inform Technology Transfer
The author takes a comprehensive look at the governmenti?½s policy of technology transfer, the process by which government-funded… 
2001
2001
Caution issued for HIV combination therapy with Zerit and Videx in pregnant women.
2000
2000
Stavudine (Zerit).
  • Stavudine Zerit
  • Research initiative, treatment action : RITA
  • 2000
  • Corpus ID: 35337423
Stavudine, an early nucleoside reverse transcriptase inhibitor (NRTI), was used as part of combination antiretroviral therapy for… 
2000
2000
Zerit vs. Retrovir.
Zerit (d4T) is as potent as Retrovir (AZT) in HIV combination therapy according to a University of Alabama study. This is… 
2000
2000
Death halts study.
A study of lodenosine (FddA) was halted when one of the participants died of liver failure and other participants showed signs… 
Review
1996
Review
1996
Stavudine (d4T, Zerit).
Stavudine, 2′,3′-didehydro-3′-deoxythymidine (D4T), has recently been approved by the U.S. Food and Drug Administration for the… 
1995
1995
FDA antiviral advisory hearings on lamivudine (Epivir, 3TC), saquinavir (Invirase), stavudine (Zerit, d4T), November 6-8. Food and Drug Administration.
Three different drugs are being considered by the Food and Drug Administration (FDA) Antiviral Drugs Advisory Committee in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)